Mizuho Securities USA’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Mizuho Securities USA’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-5,500	Closed	-$44K	–	235
2018 Q1	$44K	Sell	5,500 -31,500	-85%	-$769K	﹤0.01%	151
2017 Q4	$367K	Buy	+37,000	New	+$906K	0.02%	142

Other funds holding FLXN

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Mizuho Securities USA's FLXN Position: Q2 2018 in Review

Mizuho Securities USA sold out of Flexion Therapeutics, Inc. (FLXN) in Q2 2018, closing a stake of 5,500 shares — an estimated $123K sold.

Mizuho Securities USA first reported a position in FLXN in Q4 2017 and held it in 2 quarters. The position peaked at $926K in Q4 2017. 130 funds tracked by Wall St. Rank hold FLXN as of Q2 2018.

Mizuho Securities USA reported no remaining Flexion Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
Mizuho Securities USA sold 5,500 Flexion Therapeutics, Inc. shares in Q2 2018, an estimated $123K.
Mizuho Securities USA first reported a position in Flexion Therapeutics, Inc. in Q4 2017 and held it in 2 quarters.
Mizuho Securities USA's Flexion Therapeutics, Inc. position peaked at $926K in Q4 2017.
130 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2018.

Based on Mizuho Securities USA's 13F filing for Q2 2018, filed 23 Jul 2018.